CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 13.43
  • +0.19+1.44%
Market Closed Aug 12 15:00 CST
7.89BMarket Cap22.42P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-32.59%482.59M
10.81%2.17B
13.40%1.63B
19.96%1.19B
38.51%715.93M
12.55%1.96B
14.60%1.44B
13.13%995.47M
20.32%516.89M
11.15%1.74B
Operating revenue
-32.59%482.59M
10.81%2.17B
13.40%1.63B
19.96%1.19B
38.51%715.93M
12.55%1.96B
14.60%1.44B
13.13%995.47M
20.32%516.89M
11.15%1.74B
Other operating revenue
----
-30.63%3.66M
----
107.05%6.75M
----
94.55%5.27M
----
68.30%3.26M
----
-2.77%2.71M
Total operating cost
-29.15%354.63M
4.21%1.69B
9.56%1.16B
19.27%767.8M
36.02%500.56M
17.14%1.62B
10.61%1.06B
6.30%643.74M
20.64%368.02M
11.71%1.38B
Operating cost
-30.92%124.31M
3.10%586.4M
8.62%431.23M
15.09%319.24M
39.30%179.95M
27.22%568.78M
8.17%397M
2.83%277.39M
1.01%129.18M
-0.39%447.1M
Operating tax surcharges
-43.48%4.9M
3.46%37.33M
-0.73%23.8M
2.64%18.57M
39.27%8.67M
10.00%36.09M
12.29%23.97M
11.51%18.1M
4.33%6.23M
7.89%32.8M
Operating expense
-14.75%155.07M
33.35%717.86M
30.62%457.81M
59.87%273.74M
58.89%181.9M
-4.71%538.34M
13.14%350.49M
8.34%171.23M
24.92%114.48M
13.56%564.95M
Administration expense
-24.91%38.77M
-26.07%202.81M
-10.30%152.44M
-14.00%93.22M
19.82%51.63M
75.49%274.33M
55.64%169.95M
50.78%108.4M
85.39%43.09M
25.52%156.33M
Financial expense
-128.52%-1.5M
2.27%-14.41M
-2.91%-5.95M
89.65%-971.89K
5.18%5.24M
29.31%-14.74M
63.89%-5.78M
36.56%-9.39M
176.65%4.99M
-17.60%-20.86M
-Interest expense (Financial expense)
-71.99%3.05M
-19.17%16.36M
97.00%26.81M
-75.47%5.97M
194.69%10.9M
11.12%20.24M
-5.84%13.61M
--24.32M
-24.05%3.7M
57.61%18.21M
-Interest Income (Financial expense)
-4.19%-5.49M
19.86%-31.18M
-39.05%-34.48M
77.34%-7.82M
-125.51%-5.26M
0.91%-38.91M
19.69%-24.8M
---34.51M
62.44%-2.33M
-33.49%-39.27M
Research and development
-54.78%33.09M
-27.17%158.06M
-17.31%105.33M
-17.96%64M
4.43%73.16M
7.20%217.04M
-24.94%127.38M
-25.33%78.01M
11.52%70.06M
31.22%202.45M
Credit Impairment Loss
-85.52%-13.52M
99.77%-9.05K
-6,343.84%-5.42M
23.50%-5.64M
-203.50%-7.29M
-206.15%-3.91M
102.87%86.86K
-155.92%-7.37M
37.47%-2.4M
-145.87%-1.28M
Asset Impairment Loss
----
-189.21%-16.17M
-439.92%-5.17M
-96.37%55.19K
-94.82%78.75K
68.85%-5.59M
--1.52M
--1.52M
--1.52M
-4,515.89%-17.94M
Other net revenue
-3.01%-724.97K
-67.52%34.71M
-53.36%10.81M
8.21%7.49M
-116.60%-703.8K
51.43%106.89M
-65.20%23.19M
-63.61%6.93M
196.75%4.24M
170.61%70.59M
Fair value change income
----
631.94%1.19M
8.58%-836.6K
5.01%-869.26K
----
-90.79%162.92K
31.65%-915.14K
31.65%-915.14K
31.65%-915.14K
32.05%1.77M
Invest income
-565.53%-387.46K
15.04%1.99M
4.52%-1.83M
64.01%-521.4K
109.84%83.23K
225.28%1.73M
2.42%-1.92M
69.67%-1.45M
76.14%-845.52K
119.63%532.58K
-Including: Investment income associates
----
-37,211.81%-1.14M
----
----
----
-28.04%3.07K
----
----
----
100.09%4.27K
Asset deal income
405.58%4.55M
-94.67%1.67M
-2,325.76%-2.35M
-333,029.09%-2.56M
---1.49M
106.58%31.24M
-99.32%105.7K
-100.00%-769.7
----
--15.12M
Other revenue
9.05%8.63M
-44.70%46.04M
8.71%26.42M
12.49%17.03M
14.97%7.91M
15.01%83.25M
-57.67%24.3M
26.26%15.14M
58.54%6.88M
188.77%72.38M
Operating profit
-40.73%127.23M
16.00%518.26M
19.74%477.92M
20.97%433.86M
40.20%214.66M
4.14%446.78M
10.49%399.14M
22.27%358.66M
27.44%153.11M
20.94%429.04M
Add:Non operating Income
-83.78%39.96K
-25.89%561.46K
-36.68%613.12K
-33.01%417.99K
-58.03%246.39K
-14.84%757.61K
47.78%968.22K
-26.20%624K
316.46%587.1K
674.83%889.62K
Less:Non operating expense
-35.41%74.95K
-60.22%540.68K
-76.92%953.75K
49.10%319.71K
-3.18%116.03K
56.74%1.36M
873.46%4.13M
74.74%214.43K
32.00%119.85K
-91.89%867.09K
Total profit
-40.78%127.19M
16.16%518.28M
20.61%477.58M
20.85%433.96M
39.86%214.79M
3.99%446.18M
9.55%395.98M
22.11%359.07M
27.77%153.58M
24.67%429.06M
Less:Income tax cost
-40.36%27.18M
-16.86%96.99M
12.70%80.68M
-3.10%54.42M
35.91%45.57M
36.69%116.65M
4.41%71.59M
19.82%56.16M
48.82%33.53M
27.10%85.34M
Net profit
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
22.92%120.05M
24.08%343.72M
Net profit from continuing operation
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
22.92%120.05M
24.08%343.72M
Net profit of parent company owners
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
22.92%120.05M
24.08%343.72M
Earning per share
Basic earning per share
-41.38%0.17
28.57%0.72
23.64%0.68
22.64%0.65
38.10%0.29
-6.67%0.56
8.03%0.55
23.26%0.53
23.53%0.21
25.00%0.6
Diluted earning per share
-41.38%0.17
28.57%0.72
23.64%0.68
22.64%0.65
38.10%0.29
-6.67%0.56
8.03%0.55
23.26%0.53
23.53%0.21
25.00%0.6
Other composite income
-377.78%-9.27M
-260.78%-36.85M
-294.63%-25.34M
-253.84%-9.3M
-292.03%-1.94M
953.45%22.92M
802.28%13.02M
618.03%6.04M
-494.97K
-134.95%-2.69M
Other composite income of parent company owners
-377.78%-9.27M
-260.78%-36.85M
-294.63%-25.34M
-253.84%-9.3M
-292.03%-1.94M
953.45%22.92M
802.28%13.02M
618.03%6.04M
---494.97K
-134.95%-2.69M
Total composite income
-45.75%90.75M
9.08%384.45M
10.12%371.55M
19.84%370.25M
39.92%167.28M
3.35%352.45M
15.93%337.4M
25.58%308.96M
22.41%119.56M
23.62%341.03M
Total composite income of parent company owners
-45.75%90.75M
9.08%384.45M
10.12%371.55M
19.84%370.25M
39.92%167.28M
3.35%352.45M
15.93%337.4M
25.58%308.96M
22.41%119.56M
23.62%341.03M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -32.59%482.59M10.81%2.17B13.40%1.63B19.96%1.19B38.51%715.93M12.55%1.96B14.60%1.44B13.13%995.47M20.32%516.89M11.15%1.74B
Operating revenue -32.59%482.59M10.81%2.17B13.40%1.63B19.96%1.19B38.51%715.93M12.55%1.96B14.60%1.44B13.13%995.47M20.32%516.89M11.15%1.74B
Other operating revenue -----30.63%3.66M----107.05%6.75M----94.55%5.27M----68.30%3.26M-----2.77%2.71M
Total operating cost -29.15%354.63M4.21%1.69B9.56%1.16B19.27%767.8M36.02%500.56M17.14%1.62B10.61%1.06B6.30%643.74M20.64%368.02M11.71%1.38B
Operating cost -30.92%124.31M3.10%586.4M8.62%431.23M15.09%319.24M39.30%179.95M27.22%568.78M8.17%397M2.83%277.39M1.01%129.18M-0.39%447.1M
Operating tax surcharges -43.48%4.9M3.46%37.33M-0.73%23.8M2.64%18.57M39.27%8.67M10.00%36.09M12.29%23.97M11.51%18.1M4.33%6.23M7.89%32.8M
Operating expense -14.75%155.07M33.35%717.86M30.62%457.81M59.87%273.74M58.89%181.9M-4.71%538.34M13.14%350.49M8.34%171.23M24.92%114.48M13.56%564.95M
Administration expense -24.91%38.77M-26.07%202.81M-10.30%152.44M-14.00%93.22M19.82%51.63M75.49%274.33M55.64%169.95M50.78%108.4M85.39%43.09M25.52%156.33M
Financial expense -128.52%-1.5M2.27%-14.41M-2.91%-5.95M89.65%-971.89K5.18%5.24M29.31%-14.74M63.89%-5.78M36.56%-9.39M176.65%4.99M-17.60%-20.86M
-Interest expense (Financial expense) -71.99%3.05M-19.17%16.36M97.00%26.81M-75.47%5.97M194.69%10.9M11.12%20.24M-5.84%13.61M--24.32M-24.05%3.7M57.61%18.21M
-Interest Income (Financial expense) -4.19%-5.49M19.86%-31.18M-39.05%-34.48M77.34%-7.82M-125.51%-5.26M0.91%-38.91M19.69%-24.8M---34.51M62.44%-2.33M-33.49%-39.27M
Research and development -54.78%33.09M-27.17%158.06M-17.31%105.33M-17.96%64M4.43%73.16M7.20%217.04M-24.94%127.38M-25.33%78.01M11.52%70.06M31.22%202.45M
Credit Impairment Loss -85.52%-13.52M99.77%-9.05K-6,343.84%-5.42M23.50%-5.64M-203.50%-7.29M-206.15%-3.91M102.87%86.86K-155.92%-7.37M37.47%-2.4M-145.87%-1.28M
Asset Impairment Loss -----189.21%-16.17M-439.92%-5.17M-96.37%55.19K-94.82%78.75K68.85%-5.59M--1.52M--1.52M--1.52M-4,515.89%-17.94M
Other net revenue -3.01%-724.97K-67.52%34.71M-53.36%10.81M8.21%7.49M-116.60%-703.8K51.43%106.89M-65.20%23.19M-63.61%6.93M196.75%4.24M170.61%70.59M
Fair value change income ----631.94%1.19M8.58%-836.6K5.01%-869.26K-----90.79%162.92K31.65%-915.14K31.65%-915.14K31.65%-915.14K32.05%1.77M
Invest income -565.53%-387.46K15.04%1.99M4.52%-1.83M64.01%-521.4K109.84%83.23K225.28%1.73M2.42%-1.92M69.67%-1.45M76.14%-845.52K119.63%532.58K
-Including: Investment income associates -----37,211.81%-1.14M-------------28.04%3.07K------------100.09%4.27K
Asset deal income 405.58%4.55M-94.67%1.67M-2,325.76%-2.35M-333,029.09%-2.56M---1.49M106.58%31.24M-99.32%105.7K-100.00%-769.7------15.12M
Other revenue 9.05%8.63M-44.70%46.04M8.71%26.42M12.49%17.03M14.97%7.91M15.01%83.25M-57.67%24.3M26.26%15.14M58.54%6.88M188.77%72.38M
Operating profit -40.73%127.23M16.00%518.26M19.74%477.92M20.97%433.86M40.20%214.66M4.14%446.78M10.49%399.14M22.27%358.66M27.44%153.11M20.94%429.04M
Add:Non operating Income -83.78%39.96K-25.89%561.46K-36.68%613.12K-33.01%417.99K-58.03%246.39K-14.84%757.61K47.78%968.22K-26.20%624K316.46%587.1K674.83%889.62K
Less:Non operating expense -35.41%74.95K-60.22%540.68K-76.92%953.75K49.10%319.71K-3.18%116.03K56.74%1.36M873.46%4.13M74.74%214.43K32.00%119.85K-91.89%867.09K
Total profit -40.78%127.19M16.16%518.28M20.61%477.58M20.85%433.96M39.86%214.79M3.99%446.18M9.55%395.98M22.11%359.07M27.77%153.58M24.67%429.06M
Less:Income tax cost -40.36%27.18M-16.86%96.99M12.70%80.68M-3.10%54.42M35.91%45.57M36.69%116.65M4.41%71.59M19.82%56.16M48.82%33.53M27.10%85.34M
Net profit -40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M22.92%120.05M24.08%343.72M
Net profit from continuing operation -40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M22.92%120.05M24.08%343.72M
Net profit of parent company owners -40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M22.92%120.05M24.08%343.72M
Earning per share
Basic earning per share -41.38%0.1728.57%0.7223.64%0.6822.64%0.6538.10%0.29-6.67%0.568.03%0.5523.26%0.5323.53%0.2125.00%0.6
Diluted earning per share -41.38%0.1728.57%0.7223.64%0.6822.64%0.6538.10%0.29-6.67%0.568.03%0.5523.26%0.5323.53%0.2125.00%0.6
Other composite income -377.78%-9.27M-260.78%-36.85M-294.63%-25.34M-253.84%-9.3M-292.03%-1.94M953.45%22.92M802.28%13.02M618.03%6.04M-494.97K-134.95%-2.69M
Other composite income of parent company owners -377.78%-9.27M-260.78%-36.85M-294.63%-25.34M-253.84%-9.3M-292.03%-1.94M953.45%22.92M802.28%13.02M618.03%6.04M---494.97K-134.95%-2.69M
Total composite income -45.75%90.75M9.08%384.45M10.12%371.55M19.84%370.25M39.92%167.28M3.35%352.45M15.93%337.4M25.58%308.96M22.41%119.56M23.62%341.03M
Total composite income of parent company owners -45.75%90.75M9.08%384.45M10.12%371.55M19.84%370.25M39.92%167.28M3.35%352.45M15.93%337.4M25.58%308.96M22.41%119.56M23.62%341.03M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg